As previously reported, Craig-Hallum initiated coverage of Agiliti with a Buy rating and $23 price target. The firm notes that after helping hospitals deal with a massive influx of patients during COVID, which drove adoption and strong financial performance, the past year has been rough. Craig-Hallum believes the corner is being turned and as a result Agiliti can return to high single digit revenue growth.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AGTI:
